Human Pathology
Volume 41, Issue 6 , Pages 877-885 , June 2010

P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance

  • Min A. Kim, MD, PhD

      Affiliations

    • Department of Pathology, Seoul National University College of Medicine, Seoul 110-799, Korea
    • ,
  • Eun Ji Jung, MS

      Affiliations

    • Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea
    • ,
  • Hye Seung Lee, MD, PhD

      Affiliations

    • Department of Pathology, Seoul National University Bundang Hospital, Gyeonggi 463-707, Korea
    • ,
  • Hee Eun Lee, MD, PhD

      Affiliations

    • Department of Pathology, Seoul National University Bundang Hospital, Gyeonggi 463-707, Korea
    • ,
  • Han-Kwang Yang, MD, PhD

      Affiliations

    • Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea
    • Department of Surgery, Seoul National University College of Medicine, Seoul 110-799, Korea
    • ,
  • Do-Youn Oh, MD, PhD

      Affiliations

    • Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea
    • Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea
    • ,
  • Yung-Jue Bang, MD, PhD

      Affiliations

    • Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea
    • Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea
    • ,
  • Woo Ho Kim, MD, PhD

      Affiliations

    • Department of Pathology, Seoul National University College of Medicine, Seoul 110-799, Korea
    • Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea
    • Corresponding Author InformationCorresponding author. Department of Pathology, Seoul National University College of Medicine, Seoul 110-799, Korea.

Received 4 December 2008 ,Revised 24 April 2009 ,Accepted 28 April 2009.

References 

  1. Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305–315
  2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96
  3. Kim MA, Jung EJ, Lee HS, et al. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction. Hum Pathol. 2007;38:1386–1393
  4. Kim MA, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology. 2008;52:738–746
  5. Kim HS, Lee BL, Woo DK, Bae SI, Kim WH. Assessment of markers for the identification of microsatellite instability phenotype in gastric neoplasms. Cancer Lett. 2001;164:61–68
  6. Lee HS, Chang MS, Yang HK, Lee BL, Kim WH. Epstein-Barr virus–positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin Cancer Res. 2004;10:1698–1705
  7. Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab Invest. 2003;83:519–526
  8. Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development. 1988;102:639–655
  9. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. Cadherin switching. J Cell Sci. 2008;121:727–735
  10. Nose A, Takeichi M. A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos. J Cell Biol. 1986;103:2649–2658
  11. Shimoyama Y, Hirohashi S, Hirano S, et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 1989;49:2128–2133
  12. Lo Muzio L, Pannone G, Mignogna MD, et al. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas. Histol Histopathol. 2004;19:1089–1099
  13. Paredes J, Albergaria A, Oliveira JT, Jeronimo C, Milanezi F, Schmitt FC. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res. 2005;11:5869–5877
  14. Peralta Soler A, Knudsen KA, Salazar H, Han AC, Keshgegian AA. P-cadherin expression in breast carcinoma indicates poor survival. Cancer. 1999;86:1263–1272
  15. Stefansson IM, Salvesen HB, Akslen LA. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. J Clin Oncol. 2004;22:1242–1252
  16. Patel IS, Madan P, Getsios S, Bertrand MA, MacCalman CD. Cadherin switching in ovarian cancer progression. Int J Cancer. 2003;106:172–177
  17. Munoz-Guerra MF, Marazuela EG, Fernandez-Contreras ME, Gamallo C. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indication of poor prognosis. Cancer. 2005;103:960–969
  18. Sprecher E, Bergman R, Richard G, et al. Hypotrichosis with juvenile muscular dystrophy is caused by a mutation in CDH3 encoding P-cadherin. Nat Genet. 2001;29:134–136
  19. Indelman M, Eason J, Hummel M, et al. Novel CDH3 mutations in hypotrichosis with juvenile muscular dystrophy. Clin Exp Dermatol. 2007;32:191–196
  20. Van Marck V, Stove C, Van Den Bossche K, et al. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer Res. 2005;65:8774–8783
  21. Tsutsumida A, Hamada J, Tada M, et al. Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines. Int J Oncol. 2004;25:1415–1421
  22. Shimoyama Y, Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res. 1991;51:2185–2192
  23. Yasui W, Sano T, Nishimura K, et al. Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression. Int J Cancer. 1993;54:49–52
  24. Tannapfel A, Yasui W, Yokozaki H, Wittekind C, Tahara E. Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines. Virchows Arch. 1994;425:139–144
  25. Lee HE, Jee CD, Kim MA, et al. Loss of promyelocytic leukemia protein in human gastric cancers. Cancer Lett. 2007;247:103–109
  26. Correa P, Shiao YH. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res. 1994;54:1941s–1943s
  27. Tahara E. Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer. 1995;75:1410–1417
  28. Rosivatz E, Becker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002;161:1881–1891
  29. Castro Alves C, Rosivatz E, Schott C, et al. Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol. 2007;211:507–515
  30. Kim MA, Lee HS, Lee HE, Kim JH, Yang HK, Kim WH. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathol. 2009;54:442–451
  31. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119:265–272
  32. Kim TY, Lee HJ, Hwang KS, et al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest. 2004;84:479–484
  33. Graziano F, Arduini F, Ruzzo A, et al. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients. with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol. 2004;15:489–492
  34. Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2:84–89
  35. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76–83
  36. Kamei T, Matozaki T, Sakisaka T, et al. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells-regulation by Rho, Rac and Rab small G proteins. Oncogene. 1999;18:6776–6784
  37. St Croix B, Sheehan C, Rak JW, et al. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol. 1998;142:557–571

☆ This study was supported by a grant (A080316) of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea.

PII: S0046-8177(09)00436-5

doi: 10.1016/j.humpath.2009.04.031

Human Pathology
Volume 41, Issue 6 , Pages 877-885 , June 2010

Article Tools

* Image Usage & Resolution